Loading organizations...
Loading organizations...
Provider of cancer treatment solutions.
BAKX Therapeutics has raised $25.0M across 1 funding round.
BAKX Therapeutics has raised $25.0M in total across 1 funding round.
BAKX Therapeutics has raised $25.0M in total across 1 funding round.
BAKX Therapeutics's investors include Yibing Shan, Philippe Lopes-Fernandes, Sherpa Healthcare Partners.
BAKX Therapeutics has raised $25.0M across 1 funding round. Most recently, it raised $25.0M Series A in November 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 18, 2021 | $25.0M Series A | Yibing Shan | Philippe Lopes-Fernandes, Sherpa Healthcare Partners |